Last deal

$5M

Amount

Post-IPO Equity

Stage

20.05.2024

Date

3

all rounds

$51.8M

Total amount

date founded

Financing round

General

About Company
Coya Therapeutics is a clinical-stage biotechnology company developing treatments for inflammation and neuroinflammation.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2020

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Based in Houston, TX, Coya Therapeutics is focused on developing innovative therapies for neurodegenerative, autoimmune, and metabolic diseases. Their product pipeline includes Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. The company's goal is to restore the anti-inflammatory and immunomodulatory functions of Tregs to address the unmet medical needs of patients. Coya's 300 Series product candidates, COYA 301 and COYA 302, aim to enhance Treg function and expand Treg numbers through different mechanisms. COYA 301 is a cytokine biologic for subcutaneous administration, while COYA 302 is a biologic combination for subcutaneous and/or intravenous administration. By targeting systemic inflammation and neuroinflammation, Coya Therapeutics aims to provide disease-modifying approaches for patients with serious conditions such as ALS, Parkinson's, Alzheimer's, and autoimmune diseases.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Cara Therapeutics

Cara Therapeutics

Cara Therapeutics is a biotechnology company developing therapeutics to treat pain, inflammation and pruritus.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Shelton, CT 06484, USA

total rounds

10

total raised

$517.2M
Inotrem

Inotrem

Inotrem is a biotech company specializing in immunotherapy for inflammatory syndromes.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Paris, France

total rounds

8

total raised

$142.32M
Aviceda Therapeutics

Aviceda Therapeutics

Aviceda Therapeutics is a biotech company developing drugs for treating glyco-immune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Cambridge, MA, USA

total rounds

3

total raised

$69.31M
Palatin Technologies

Palatin Technologies

Palatin is a biopharmaceutical company developing medicines that target the melanocortin peptide receptor system.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cranbury, NJ, USA

total rounds

9

total raised

$133.9M

Financials

Funding Rounds
4
3

Number of Funding Rounds

$51.8M

Money Raised

Their latest funding was raised on 20.05.2024. Their latest investor Alzheimer's Drug Discovery Foundation. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Alzheimer's Drug Discovery Foundation

Alzheimer's Drug Discovery Foundation

The Alzheimer’s Drug Discovery Foundation finds drugs for Alzheimer’s disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

count Of Investments

35

count Of Exists

1
Wilbur Ross

Wilbur Ross

Wilbur Ross Jr is the chairman and chief executive officer of WL Ross & Co. LLC, a merchant banking firm, a position that he has held since April 2000. WL Ross & Co is part of Invesco Private Capital, a listed company, of which Ross is chairman. As such, Ross is also the chairman and chief executive officer of several unlisted Invesco portfolio companies. Ross is the chairman of Ohizumi Manufacturing Company in Japan, International Textile Group and Diamond S Shipping, all of which are unlisted companies, and of the Japan Society and the Economics Studies Council of the Brookings Institution, which are non-profit entities. Wilbur L Ross is a director of International Automotive Components and Compagnie Européenne de Wagons SARL (Luxembourg), both non-listed companies, and also a director of the Yale School of Management and the Harvard Business School Dean’s Advisory Board. He sits on the boards of Air Lease Corp., Assured Guaranty, BankUnited, EXCO Resources and Greenbrier, all NYSE-listed, and of PLASCAR, which is listed in Brazil. Ross holds an M.B.A. with distinction from Harvard University and an A.B. from Yale University.

current job

W.L. Ross & Co
W.L. Ross & Co

count Of Investments

1
Co-Investors
Investors
3
3

Number of lead investors

3

Number of investors

Investor 
Lead 
Round 
Partners 
Alzheimer's Drug Discovery Foundation

Alzheimer's Drug Discovery Foundation

The Alzheimer’s Drug Discovery Foundation finds drugs for Alzheimer’s disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

count Of Investments

35

count Of Exists

1
Wilbur Ross

Wilbur Ross

Wilbur Ross Jr is the chairman and chief executive officer of WL Ross & Co. LLC, a merchant banking firm, a position that he has held since April 2000. WL Ross & Co is part of Invesco Private Capital, a listed company, of which Ross is chairman. As such, Ross is also the chairman and chief executive officer of several unlisted Invesco portfolio companies. Ross is the chairman of Ohizumi Manufacturing Company in Japan, International Textile Group and Diamond S Shipping, all of which are unlisted companies, and of the Japan Society and the Economics Studies Council of the Brookings Institution, which are non-profit entities. Wilbur L Ross is a director of International Automotive Components and Compagnie Européenne de Wagons SARL (Luxembourg), both non-listed companies, and also a director of the Yale School of Management and the Harvard Business School Dean’s Advisory Board. He sits on the boards of Air Lease Corp., Assured Guaranty, BankUnited, EXCO Resources and Greenbrier, all NYSE-listed, and of PLASCAR, which is listed in Brazil. Ross holds an M.B.A. with distinction from Harvard University and an A.B. from Yale University.

current job

W.L. Ross & Co
W.L. Ross & Co

count Of Investments

1
Allele Capital Partners

Allele Capital Partners

Allele Capital Partners provides venture capital and private equity financing to life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Location

Boca Raton, FL, USA

count Of Investments

1

Howard Berman

Howard Berman is Board of Advisor at The Washington Institute for Near East Policy.

current job

Coya Therapeutics
Coya Therapeutics

People

Founders
1

Howard Berman

Howard Berman is Board of Advisor at The Washington Institute for Near East Policy.

current job

Coya Therapeutics
Coya Therapeutics

Howard Berman

Employee Profiles
8
Arun Swaminathan

Arun Swaminathan

Chief Business Officer

David S. Snyder

CFO and COO

David Snyder

David Snyder

CFO & COO

Gene Mack

Gene Mack

Chief Financial Officer

Howard Berman

Howard Berman

Founder and Chief Executive Officer

Adrian Hepner

Adrian Hepner

Chief Medical Officer

Greg MacMichael

Chief Technical Officer

Howard Berman

Founder and Chief Executive Officer

Activity

Recent News
47
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week